News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Oral blarcamesine delivers long-term benefit in early AD
24 Oct 2025
byAudrey Abella
Findings from the phase IIb/III ATTENTION-AD study reflect the continued benefit of oral blarcamesine in individuals with early Alzheimer’s disease (AD) after receiving the drug continuously for up to 4 years.
24 Oct 2025

Polygenic risk score shows promise in predicting future breast cancer events
23 Oct 2025
byAudrey Abella
A retrospective analysis shows the potential of the 313-SNP breast cancer (BC) polygenic risk score (PRS313) blood test to predict future in situ or invasive breast disease in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS).
23 Oct 2025






